Article
ALCAM: A Novel Surface Marker on EpCAMlow Circulating Tumor Cells
2022-07-12
Abstract excerpt
<h4>Background: </h4> Current strategies in circulating tumor cell (CTC) isolation in pancreatic cancer heavily rely on the EpCAM and cytokeratin cell status. EpCAM is generally not considered as a good marker given its transitory change during Epithelial to Mesenchymal Transition (EMT) or reverse EMT. There is a need to identify other surface markers to capture the complete repertoire of PDAC CTCs. The primary ob...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- be6b2b5a-c52d-5cf4-9960-c717348925e7
- DOI
- 10.20944/preprints202207.0178.v1
